Form4insider filings, from the source

SEC Form 4 · accession 0001654954-19-000381

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Myron Kaplan
Director
Period of report
Jan 10, 2019
Accepted (ET)
Jan 11, 2019 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Restricted Stock UnitsF1Jan 10, 2019A12,500—A443,666D
Restricted Stock UnitsF1Jan 10, 2019A15,000—A458,666D
Restricted Stock UnitsF1Jan 10, 2019A10,000—A468,666D
Restricted Stock UnitsF1Jan 10, 2019A5,000—A473,666D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy Common Stock)F2$1.66Jan 10, 2019A75,000A—Jan 10, 2029Common Stock75,00075,000D
Stock Option (Right to Buy Common Stock)F3$0.57holding————Feb 16, 2028Common Stock40,00040,000D
Stock Option (Right to Buy Common Stock)F4$2.24holding————Feb 21, 2027Common Stock40,00040,000D
Stock Option (Right to Buy Common Stock)F5$4.28holding————Apr 28, 2026Common Stock50,00050,000D

Explanation of responses